| Financial Year |
March 31 2023 |
| Monetary Funds |
434,577,090.38 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
-- |
| Accounts Receivable |
236,611,636.55 |
| Advances to Suppliers |
10,008,235.80 |
| Other Receivables |
4,236,712.74 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
440,809,988.49 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
17,286,903.49 |
| Total Current Assets |
1,144,330,567.45 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
-- |
| Investment Properties |
-- |
| Fixed Assetes |
592,845,781.96 |
| Under-construction Projects |
85,027,941.81 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
121,843,376.69 |
| R&D expenses |
-- |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
10,719,413.96 |
| Deferred Income Tax Assets |
11,628,677.34 |
| Other Non-Current Assets |
72,453,064.78 |
| Sub-Total of Non-Current Assets |
965,213,870.82 |
| Total Assets |
2,109,544,438.27 |
| Short-Term Loans |
35,596,258.96 |
| Trading Financial liabilities |
-- |
| Notes Payable |
49,541,732.00 |
| Accounts Payable |
115,442,071.66 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
19,973,954.68 |
| Taxes Payable |
19,567,578.23 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
94,582,301.52 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
6,197,328.79 |
| Other Current Liabilities |
279,167.29 |
| Sub-Total of Current Liabilities |
343,468,283.89 |
| Long-term Loans |
3,902,427.91 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
2,272,444.42 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
25,029,458.44 |
| Total Liabilities |
368,497,742.33 |
| Paid-In Capital(Or Share Stock) |
406,195,000.00 |
| Capital Surplus |
562,648,037.17 |
| Surplus Reserve |
71,416,814.77 |
| LESS:Treasury Stock |
57,145,000.00 |
| Undistributed Profits |
725,940,357.23 |
| Minority Stockholder's Interest |
7,971,246.32 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
1,733,075,449.62 |
| Owner's Equity（Stockholder's Equity） |
1,741,046,695.94 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
2,109,544,438.27 |
